Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 03, 2018 |
referred to health returned to senate died in assembly |
Apr 24, 2017 |
referred to health delivered to assembly passed senate |
Mar 13, 2017 |
advanced to third reading |
Mar 08, 2017 |
2nd report cal. |
Mar 07, 2017 |
1st report cal.380 |
Jan 04, 2017 |
referred to health |
Senate Bill S300
2017-2018 Legislative Session
Sponsored By
(R, C, G, IP, SC) Senate District
Archive: Last Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
co-Sponsors
(R, C, IP, RFM) Senate District
(R, C, IP) Senate District
(D) Senate District
(R) Senate District
2017-S300 (ACTIVE) - Details
- Current Committee:
- Senate Health
- Law Section:
- Public Health Law
- Laws Affected:
- Amd §3306, Pub Health L
- Versions Introduced in 2015-2016 Legislative Session:
-
S7397
2017-S300 (ACTIVE) - Sponsor Memo
BILL NUMBER: S300 TITLE OF BILL : An act to amend the public health law, in relation to designating Xylazine as a schedule III depressant PURPOSE : This bill designates Xylazine as a schedule III controlled substance. SUMMARY OF PROVISIONS : Section one amends subdivision (c) of schedule III of section 3306 of the public health law, regarding schedules of controlled substances, to add a new paragraph 15 to include Xylazine (N(2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine) as a schedule III controlled substance. Section two establishes the effective date. JUSTIFICATION : Xylazine is a veterinary sedative primarily used on horses during substantially painful procedures such as castration and dental work. Much like ketamine, which was classified under New York law as a
2017-S300 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 300 2017-2018 Regular Sessions I N S E N A T E (PREFILED) January 4, 2017 ___________ Introduced by Sens. MURPHY, AKSHAR, AMEDORE, O'MARA, ORTT -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to designating Xyla- zine as a schedule III depressant THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision (c) of schedule III of section 3306 of the public health law is amended by adding a new paragraph 15 to read as follows: (15) XYLAZINE (N-(2,6-DIMETHYLPHENYL)-5,6-DIHYDRO-4H-1,3 THIAZIN-2- AMINE). § 2. This act shall take effect on the ninetieth day after it shall have become a law. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02324-01-7
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.